Search for: "Sabatelli"
Results 1 - 20
of 45
Sorted by Relevance
|
Sort by Date
20 Jul 2009, 3:10 pm
LensCrafters fired Sabatelli in March for "unspecified customer complaints," leaving Sabatelli without any medical benefits. [read post]
28 Oct 2020, 3:55 pm
In Sabatelli v. [read post]
18 Feb 2016, 9:59 pm
Sabatelli** -- Some of the earliest evidence for the relationship between the microbiome and obesity came from studies of antibiotics and... [read post]
13 May 2014, 9:59 pm
Sabatelli* -- What does grapefruit juice, or more specifically pomelo juice, have to do with all this? [read post]
3 Oct 2017, 9:59 pm
Sabatelli -- Antibiotic resistance is a major problem in the United States and is considered by the World Health Organization (WHO) to be one of the largest threats to human health. [read post]
10 Aug 2015, 9:59 pm
Sabatelli** -- This is the first installment in a series on advancements in microbiome research and development. [read post]
11 Oct 2017, 8:46 am
Steve Brachmann: PTAB Due Process Violations Raised In Brief To Federal Circuit Joe Mullin: New Patent-Holder Grabs Nokia Patents, Sues Over Apple iPhones Michael Hinrichsen & Anthony Sabatelli: Patent Exhaustion And Pharmaceuticals Jo Dale Carothers: Federal Circuit Clarifies Venue Requirements For Patent Cases Florian Mueller: DoJ Backs Apple, Says Supreme Court Should Deny Samsung’s Most Recent Cert Petition Upcoming Events The Power Of The PTAB: The New Authority In Patent Law… [read post]
21 Jun 2018, 9:59 pm
Sabatelli** -- "Your hair is your crowning glory" is an often-quoted phrase with biblical roots.1 Perhaps more importantly, one's hair is a visible barometer of one's health and age. [read post]
28 Aug 2022, 8:51 pm
Sabatelli** -- Decades after the science-fiction visions of Stanley Kubrick’s 2001: A Space Odyssey and Isaac Asimov’s I, Robot, artificial intelligence ("AI") is finally moving to the mainstream. [read post]
10 Oct 2017, 9:59 pm
Sabatelli** -- On May 30th, the Supreme Court ruled in Impression Products, Inc. v. [read post]
11 Jun 2014, 9:59 pm
Sabatelli of Dilworth IP LLC, who appeared in the forum's first group of... [read post]
6 Jun 2018, 8:59 pm
Sabatelli** -- Nanoparticles have been used in cancer and other diseases as both diagnostics and therapeutic agents; for example, magnetic nanoparticles for theranostics, quantum dots for bioimaging, nanoparticles as cancer biomarkers and for cancer therapy, and nanoparticles as drug delivery carriers. [read post]
31 Oct 2016, 9:59 pm
Sabatelli** -- Introduction Cancer immunotherapy or immuno-oncology (I-O) has gone mainstream. [read post]
28 Jan 2019, 9:34 pm
By Brittany Knight* and Anthony Sabatelli** -- The past year was a big year for FDA approved new drugs and biologics -- 59 in fact, compared to 46 in 2017 and a mere 22 in 2016. [read post]
17 Jul 2017, 9:59 pm
Sabatelli** -- Knowledge of, and interest in, the human microbiome has rapidly expanded in recent years: each week, there seems to be additional advancements in our understanding of the microbial communities that call our bodies home. [read post]
26 Sep 2017, 9:35 pm
Sabatelli** -- As we have discussed in previous installments of "The Emergent Microbiome," we have seen a distinct growth in the interest of the microbial communities found in our environment beyond the confines of the human body. [read post]
13 Dec 2018, 9:36 pm
By Brittany Knight* and Anthony Sabatelli** -- Software is a generic term to refer to a collection of data or executing code used by a computer to implement arithmetic operations or logical operations. [read post]
3 Oct 2018, 9:55 pm
Sabatelli** -- Typically, we think of patents as the main tool that allows for product exclusivity in the pharmaceutical industry. [read post]
11 Aug 2015, 9:59 pm
Sabatelli** -- Microbiome-related therapies typically involve compositions containing bacteria -- often called probiotics -- that treat disease or promote health. [read post]
19 Jul 2018, 8:28 pm
Sabatelli**, and Jonathan Schuchardt*** -- Buried amidst the flurry of recent Federal Circuit subject matter eligibility decisions is a question that could significantly change how Section 101 is applied in patent litigation. [read post]
